Why McKesson Is Poised to Keep Rallying

Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, pharmaceutical distributor McKesson (NYSE: MCK  ) has earned a coveted five-star ranking.

With that in mind, let's take a closer look at McKesson and see what CAPS investors are saying about the stock right now.

McKesson facts

Headquarters (Founded)

San Francisco (1833)

Market Cap

$24.5 billion

Industry

Health-care distributors

Trailing-12-Month Revenue

$123.2 billion

Management

Chairman/CEO John Hammergren
CFO Jeffrey Campbell

Return on Equity (Average, Past 3 Years)

18.8%

Cash/Debt

$2.8 billion / $3.6 billion

Dividend Yield

0.8%

Competitors

AmerisourceBergen (NYSE: ABC  )
Cardinal Health
(NYSE: CAH  )
Owens & Minor
(NYSE: OMI  )

Sources: S&P Capital IQ and Motley Fool CAPS.

On CAPS, 96% of the 619 members who have rated McKesson believe the stock will outperform the S&P 500 going forward.

Just last week, one of those Fools, brenoboyle, touched on a few of the tailwinds working in McKesson's favor: "Increasing coverage for prescription drug benefits, very shareholder friendly consistent repurchases, patent cliff for pharma will led to more generic prescription drug coverage for which [McKesson] has higher margins."

If you want market-topping returns, you need to put together the best portfolio you can. Of course, despite its five-star rating, McKesson may not be your top choice.

We've found another stock we are incredibly excited about -- excited enough to dub it "The Motley Fool's Top Stock for 2013." We have compiled a special free report for investors to uncover this stock today. The report is 100% free, but it won't be here forever, so click here to access it now.

Want to see how well (or not so well) the stocks in this series are performing? Follow the TrackPoisedTo CAPS account.


Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 2206132, ~/Articles/ArticleHandler.aspx, 7/29/2014 7:10:14 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement